Nearly 350 Patients Participate in the Foundation for Sarcoidosis Research Externally Led Patient-Focused Drug Development Meeting with the FDA [Yahoo! Finance]
aTyr Pharma, Inc. (ATYR)
Company Research
Source: Yahoo! Finance
Led Patient-Focused Drug Development (EL-PFDD) meeting on sarcoidosis with the U.S. Food and Drug Administration (FDA). This virtual event attracted nearly 350 sarcoidosis patients, caregivers, healthcare providers, industry partners, and advocates, coming together to address the critical unmet needs and challenges faced by those living with sarcoidosis. Hosted by Mary McGowan, FSR Chief Executive Officer, and moderated by John Carlin, FSR Sarc Fighter Podcast host, this interactive EL-PFDD meeting provided a platform for patients to share firsthand experiences about living with sarcoidosis, the urgent need for new sarcoidosis-specific therapies, and the symptoms and challenges they would like future therapies to prioritize. Participants engaged through sharing patient and caregiver stories, participating in topic-specific panels, live polls, call-in segments, and written submissions, making their voices heard on key issues such as symptom management, serious side-effects of some cu
Show less
Read more
Impact Snapshot
Event Time:
ATYR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATYR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATYR alerts
High impacting aTyr Pharma, Inc. news events
Weekly update
A roundup of the hottest topics
ATYR
News
- Is aTyr Pharma, Inc. (ATYR) the Best Multibagger Stock to Buy Heading into 2025? [Yahoo! Finance]Yahoo! Finance
- aTyr Pharma to Present Posters on tRNA Synthetase Candidate ATYR0101 at Keystone Symposia on Fibrosis [Yahoo! Finance]Yahoo! Finance
- aTyr Pharma to Present Posters on tRNA Synthetase Candidate ATYR0101 at Keystone Symposia on FibrosisGlobeNewswire
- aTyr Pharma Announces Third Quarter 2024 Results and Provides Corporate UpdateGlobeNewswire
- aTyr Pharma to Present at Upcoming Investor ConferencesGlobeNewswire